GlassScriptPhysician profile
Alex Pilkinton
NPI 1477182152
$10,132.72
in general payments reported to CMS, 2019-2025
14 companies · $4,831 in 2025
The $4,831 reported for 2025 was more than what 96% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $21.98 · 2022: $767 · 2023: $1,461 · 2024: $3,053 · 2025: $4,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,696 · Food and Beverage: $3,648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,695.89 |
| Food and Beverage | $3,648.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,587.01 | 2022-2025 | Citrefix, Augment Injectable, Hoffmann |
| Orthofix Medical, INC. | $3,331.29 | 2024-2025 | Truelok |
| Vilex LLC | $1,794.51 | 2025 | Redemption, Dynex |
| Arthrex, INC. | $484.90 | 2025 | |
| Treace Medical Concepts, INC. | $270.15 | 2025 | |
| Cosa Medical, LLC | $129.16 | 2025 | |
| Integra Lifesciences Corporation | $119.49 | 2022 | |
| Bioventus LLC | $119.10 | 2024 | Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $75.71 | 2023 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $66.15 | 2021-2025 | Grafix Pl, Pico 7 |
| Kci USA, INC. | $64.85 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C. Veraflo |
| Solventum Corporation | $41.46 | 2025 | Activ.A.C., Prevena |
| Biocomposites INC | $29.42 | 2025 | Stimulan |
| Merck Sharp & Dohme LLC | $19.52 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Pilkinton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.